Request Free Sample ×
US Biopsy Devices Market Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Biopsy Devices Market

ID: MRFR/MED/18046-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026

US Biopsy Devices Market Research Report: Size, Share, Trend Analysis By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Applications (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others) and By End Users (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Biopsy Devices Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Product Type (USD Million)
  49.     4.1.1 biopsy guns
  50.     4.1.2 biopsy guidance system
  51.     4.1.3 biopsy needles
  52.     4.1.4 biopsy forceps
  53.     4.1.5 localization wires
  54.     4.1.6 others
  55.   4.2 Healthcare, BY Application (USD Million)
  56.     4.2.1 breast biopsy
  57.     4.2.2 prostate biopsy
  58.     4.2.3 liver biopsy
  59.     4.2.4 lung biopsy
  60.     4.2.5 gynecological biopsy
  61.     4.2.6 others
  62.   4.3 Healthcare, BY Guidance Technique (USD Million)
  63.     4.3.1 ultrasound-guided biopsy
  64.     4.3.2 stereotactic guided biopsy
  65.     4.3.3 MRI-guided biopsy
  66.     4.3.4 CT guided biopsy
  67.     4.3.5 others
  68.   4.4 Healthcare, BY End User (USD Million)
  69.     4.4.1 hospitals & clinics
  70.     4.4.2 diagnostic & imaging centers
  71.     4.4.3 academic & research institutes
  72.     4.4.4 others
  73. 5 SECTION V: COMPETITIVE ANALYSIS
  74.   5.1 Competitive Landscape
  75.     5.1.1 Overview
  76.     5.1.2 Competitive Analysis
  77.     5.1.3 Market share Analysis
  78.     5.1.4 Major Growth Strategy in the Healthcare
  79.     5.1.5 Competitive Benchmarking
  80.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  81.     5.1.7 Key developments and growth strategies
  82.       5.1.7.1 New Product Launch/Service Deployment
  83.       5.1.7.2 Merger & Acquisitions
  84.       5.1.7.3 Joint Ventures
  85.     5.1.8 Major Players Financial Matrix
  86.       5.1.8.1 Sales and Operating Income
  87.       5.1.8.2 Major Players R&D Expenditure. 2023
  88.   5.2 Company Profiles
  89.     5.2.1 Becton Dickinson and Company (US)
  90.       5.2.1.1 Financial Overview
  91.       5.2.1.2 Products Offered
  92.       5.2.1.3 Key Developments
  93.       5.2.1.4 SWOT Analysis
  94.       5.2.1.5 Key Strategies
  95.     5.2.2 Boston Scientific Corporation (US)
  96.       5.2.2.1 Financial Overview
  97.       5.2.2.2 Products Offered
  98.       5.2.2.3 Key Developments
  99.       5.2.2.4 SWOT Analysis
  100.       5.2.2.5 Key Strategies
  101.     5.2.3 Medtronic plc (IE)
  102.       5.2.3.1 Financial Overview
  103.       5.2.3.2 Products Offered
  104.       5.2.3.3 Key Developments
  105.       5.2.3.4 SWOT Analysis
  106.       5.2.3.5 Key Strategies
  107.     5.2.4 Hologic, Inc. (US)
  108.       5.2.4.1 Financial Overview
  109.       5.2.4.2 Products Offered
  110.       5.2.4.3 Key Developments
  111.       5.2.4.4 SWOT Analysis
  112.       5.2.4.5 Key Strategies
  113.     5.2.5 Thermo Fisher Scientific Inc. (US)
  114.       5.2.5.1 Financial Overview
  115.       5.2.5.2 Products Offered
  116.       5.2.5.3 Key Developments
  117.       5.2.5.4 SWOT Analysis
  118.       5.2.5.5 Key Strategies
  119.     5.2.6 Abbott Laboratories (US)
  120.       5.2.6.1 Financial Overview
  121.       5.2.6.2 Products Offered
  122.       5.2.6.3 Key Developments
  123.       5.2.6.4 SWOT Analysis
  124.       5.2.6.5 Key Strategies
  125.     5.2.7 Siemens Healthineers AG (DE)
  126.       5.2.7.1 Financial Overview
  127.       5.2.7.2 Products Offered
  128.       5.2.7.3 Key Developments
  129.       5.2.7.4 SWOT Analysis
  130.       5.2.7.5 Key Strategies
  131.     5.2.8 Fujifilm Holdings Corporation (JP)
  132.       5.2.8.1 Financial Overview
  133.       5.2.8.2 Products Offered
  134.       5.2.8.3 Key Developments
  135.       5.2.8.4 SWOT Analysis
  136.       5.2.8.5 Key Strategies
  137.     5.2.9 Cardinal Health, Inc. (US)
  138.       5.2.9.1 Financial Overview
  139.       5.2.9.2 Products Offered
  140.       5.2.9.3 Key Developments
  141.       5.2.9.4 SWOT Analysis
  142.       5.2.9.5 Key Strategies
  143.   5.3 Appendix
  144.     5.3.1 References
  145.     5.3.2 Related Reports
  146. 6 LIST OF FIGURES
  147.   6.1 MARKET SYNOPSIS
  148.   6.2 US MARKET ANALYSIS BY PRODUCT TYPE
  149.   6.3 US MARKET ANALYSIS BY APPLICATION
  150.   6.4 US MARKET ANALYSIS BY GUIDANCE TECHNIQUE
  151.   6.5 US MARKET ANALYSIS BY END USER
  152.   6.6 KEY BUYING CRITERIA OF HEALTHCARE
  153.   6.7 RESEARCH PROCESS OF MRFR
  154.   6.8 DRO ANALYSIS OF HEALTHCARE
  155.   6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  156.   6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  157.   6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
  158.   6.12 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  159.   6.13 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
  160.   6.14 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  161.   6.15 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  162.   6.16 HEALTHCARE, BY GUIDANCE TECHNIQUE, 2024 (% SHARE)
  163.   6.17 HEALTHCARE, BY GUIDANCE TECHNIQUE, 2024 TO 2035 (USD Million)
  164.   6.18 HEALTHCARE, BY END USER, 2024 (% SHARE)
  165.   6.19 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
  166.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  167. 7 LIST OF TABLES
  168.   7.1 LIST OF ASSUMPTIONS
  169.     7.1.1
  170.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  171.     7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
  172.     7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  173.     7.2.3 BY GUIDANCE TECHNIQUE, 2025-2035 (USD Million)
  174.     7.2.4 BY END USER, 2025-2035 (USD Million)
  175.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  176.     7.3.1
  177.   7.4 ACQUISITION/PARTNERSHIP
  178.     7.4.1

US Healthcare Market Segmentation

Healthcare By Product Type (USD Million, 2025-2035)

  • biopsy guns
  • biopsy guidance system
  • biopsy needles
  • biopsy forceps
  • localization wires
  • others

Healthcare By Application (USD Million, 2025-2035)

  • breast biopsy
  • prostate biopsy
  • liver biopsy
  • lung biopsy
  • gynecological biopsy
  • others

Healthcare By Guidance Technique (USD Million, 2025-2035)

  • ultrasound-guided biopsy
  • stereotactic guided biopsy
  • MRI-guided biopsy
  • CT guided biopsy
  • others

Healthcare By End User (USD Million, 2025-2035)

  • hospitals & clinics
  • diagnostic & imaging centers
  • academic & research institutes
  • others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓